Products
products details
Home > Products >
Human Apelin Peptide (1-13) Catalog Number KS021011 CAS 217082-58-1

Human Apelin Peptide (1-13) Catalog Number KS021011 CAS 217082-58-1

Product Details:
Catalog Number:
KS021011
Product Name:
Apelin (1-13) (human)
Sequence:
QRPRLSHKGPMPF-OH (trifluoroacetate Salt)
CAS NO.:
217082-58-1
Price/1mg:
$77
Purity:
≥95% (HPLC)
Molecular Formula:
C69H111N23O16S
Molecular Weight:
1550.85
Form:
Lyophilized
Storage:
Store At -20°C Or -80°C
High Light: 

Human apelin peptide

,

apelin peptide 217082-58-1

,

apelin 13 Peptide

Product Description

Apelin (1-13) (human),Catalog Number: KS021011,CAS NO.: 217082-58-1

 

Apelin 1-13 is a vasoactive peptide and one of the most potent endogenous inotropic agents known. It is one of the active peptide fragments resulting from maturation of preproapelin. It is suggested that Apelin 1-13 could be a competitive agonist to the apelin receptor, which is a class A G-protein coupled receptor and is a putative target for treatment of cardiovascular and metabolic diseases. Apelin 1-13 may undergo a pyroglutamylation at its N-terminal glutamine residue.

Products
products details
Home > Products >
Human Apelin Peptide (1-13) Catalog Number KS021011 CAS 217082-58-1

Human Apelin Peptide (1-13) Catalog Number KS021011 CAS 217082-58-1

Product Details:
Catalog Number:
KS021011
Product Name:
Apelin (1-13) (human)
Sequence:
QRPRLSHKGPMPF-OH (trifluoroacetate Salt)
CAS NO.:
217082-58-1
Price/1mg:
$77
Purity:
≥95% (HPLC)
Molecular Formula:
C69H111N23O16S
Molecular Weight:
1550.85
Form:
Lyophilized
Storage:
Store At -20°C Or -80°C
Details Link:
Https://shopping.ks-vpeptide.com/sale-470445-human-apelin-peptide-1-13-catalog-number-ks021011-cas-217082-58-1.htm
High Light: 

Human apelin peptide

,

apelin peptide 217082-58-1

,

apelin 13 Peptide

Product Description

Apelin (1-13) (human),Catalog Number: KS021011,CAS NO.: 217082-58-1

 

Apelin 1-13 is a vasoactive peptide and one of the most potent endogenous inotropic agents known. It is one of the active peptide fragments resulting from maturation of preproapelin. It is suggested that Apelin 1-13 could be a competitive agonist to the apelin receptor, which is a class A G-protein coupled receptor and is a putative target for treatment of cardiovascular and metabolic diseases. Apelin 1-13 may undergo a pyroglutamylation at its N-terminal glutamine residue.